Compare INGR & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | BCPC |
|---|---|---|
| Founded | 1906 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Major Chemicals |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.3B |
| IPO Year | 1997 | 1995 |
| Metric | INGR | BCPC |
|---|---|---|
| Price | $94.08 | $172.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $113.17 | ★ $213.50 |
| AVG Volume (30 Days) | ★ 780.0K | 256.8K |
| Earning Date | 11-05-2026 | 10-23-2026 |
| Dividend Yield | ★ 3.58% | 0.23% |
| EPS Growth | N/A | N/A |
| EPS | ★ 6.24 | 4.09 |
| Revenue | ★ $7,219,000,000.00 | $799,023,000.00 |
| Revenue This Year | N/A | $9.17 |
| Revenue Next Year | $2.08 | $5.91 |
| P/E Ratio | ★ $14.82 | $42.27 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $90.14 | $147.18 |
| 52 Week High | $123.49 | $186.15 |
| Indicator | INGR | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 50.88 |
| Support Level | $93.86 | $160.38 |
| Resistance Level | $99.65 | $176.54 |
| Average True Range (ATR) | 2.46 | 4.22 |
| MACD | -0.23 | -0.25 |
| Stochastic Oscillator | 37.52 | 35.97 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.